Clinical Trials on High Risk Prostate Cancer in Hong Kong
Total 125 results
-
Chinese University of Hong KongRecruitingProstate Cancer | Cardiovascular RiskHong Kong
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
The University of Hong KongUnknownProstatic Hyperplasia | Prostate CancerHong Kong
-
Chinese University of Hong KongNot yet recruiting
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongNot yet recruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongWithdrawn
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongWithdrawnProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingMRI | Prostate Cancer | PSAHong Kong
-
Chinese University of Hong KongRecruiting
-
The University of Hong KongHong Kong Jockey Club Charities Trust; Lok Sin Tong Benevolent Society, Kowloon and other collaboratorsRecruitingHypertension | Diabetes Mellitus, Type 2 | Medication Adherence | Polypharmacy | Medication Safety | High Risk MedicationsHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingObesity | Breast Cancer | Colorectal Cancer | Prostate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongJanssen, LPTerminated
-
Chinese University of Hong KongIpsenCompletedProstate CancerHong Kong
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
PROCEPT BioRoboticsRecruitingBenign Prostatic Hyperplasia | Localized Prostate CancerLebanon, Hong Kong, United States
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
Ferring PharmaceuticalsFerring Pharmaceuticals Korea, Ltd.CompletedProstate CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Astellas Pharma Singapore Pte. Ltd.CompletedProstate CancerHong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
VA Office of Research and DevelopmentCompletedNewly Diagnosed Oligometastatic Prostate CancerUnited States
-
St. Barnabas Medical CenterUnknownProstate CancerUnited States
-
University of California, IrvineUniversity of California, Los Angeles; Cedars-Sinai Medical Center; VA Long Beach... and other collaboratorsRecruiting
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
VA Office of Research and DevelopmentRecruitingProstate CancerUnited States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Bristol-Myers SquibbCompleted
-
US Department of Veterans AffairsCompleted
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted